Printer Friendly

Observation favoured for macular oedema patients with good visual acuity.

A new study published in the Journal of the American Medical Association has compared different forms of management for patients with good visual acuity and diabetic macular oedema involving the macular centre.

The research found that there was no significant difference in the proportion of patients who experienced a five-letter decrease in visual acuity at two years between those managed through aflibercept, laser photocoagulation and observation.

The authors concluded: "Observation without treatment unless visual acuity worsens may be a reasonable strategy for these eyes."

Baker et al. DOI: 10.1001/jama.2019.5790

To access papers by DOI numbers, visit http://dx.doi.org/

COPYRIGHT 2019 Ten Alps Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:DIABETES
Publication:Optometry Today
Date:Jun 1, 2019
Words:104
Previous Article:UK HOSPITAL DEVELOPS AI TO IDENTIFY PATIENTS LIKELY TO SKIP APPOINTMENTS.
Next Article:CET register removals.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters